| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DC71666 | MC-VA-PABC-MMAE | MC-VA-PABC-MMAE is a drug-linker conjugate for ADC. MC-VA-PABC-MMAE contains the ADCs linker (peptide MC-VA-PABC) and a potent tubulin polymerization inhibitor MMAE. |
|
| DC71667 | Aminobenzenesulfonic auristatin E TFA | Aminobenzenesulfonic auristatin E TFA is a drug-linker conjugate for ADC with potent antitumor activity by using Auristatin E (a cytotoxic tubulin modifier), linked via the ADC linker Aminobenzenesulfonic. |
|
| DC80073 | Azido-PEG4-EV-Cit-PAB-MMAE Featured | Azido-PEG4-EV-Cit-PAB-MMAE is a precursor of antibody drug conjugate. |
|
| DC71923 | Tomaymycin DM | Tomaymycin DM, a DNA alkylator, is a derivative of Tomaymycin, it is a PBD dimer, which is attached to tumor targeting antibodies to create antibody-drug conjugates (ADCs). |
|
| DC71929 | bisSP1 | bisSP1 is an antibody drug conjugates linker. |
|
| DC71930 | MDTF | MDTF is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). |
|
| DC71931 | MDTF free acid | MDTF free acid is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). |
|
| DC71932 | NHS-SS-Ph | NHS-SS-Ph is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). |
|
| DC71949 | MC-VA-PAB-Exatecan | MC-VA-PAB-Exatecan is a drug-linker conjugate for ADC. MC-VA-PAB-Exatecan contains the ADC linker (peptide MC-VA-PAB) and a DNA topoisomerase I inhibitor Exatecan. MC-VA-PAB-Exatecan synthesized ADC shows good antitumor activity. |
|
| DC71950 | Ac-Lys-Val-Cit-PABC-MMAE | Ac-Lys-Val-Cit-PABC-MMAE is a drug-linker conjugate for ADC. Ac-Lys-Val-Cit-PABC-MMAE contains the ADC linker (peptide Ac-Lys-Val-Cit-PABC) and a potent tubulin polymerization inhibitor MMAE. |
|
| DC71951 | Aminobenzenesulfonic auristatin E-d8 | Aminobenzenesulfonic auristatin E-d8 is the deuterium labeled Aminobenzenesulfonic auristatin E. Aminobenzenesulfonic auristatin E is a drug-linker conjugate for ADC. Aminobenzenesulfonic auristatin E has potent antitumor activity by using Auristatin E (a cytotoxic tubulin modifier), linked via the ADC linker Aminobenzenesulfonic. |
|
| DC72119 | Deruxtecan analog 2 | Deruxtecan analog 2 (example 9 P3) is a Deruxtecan analog. Deruxtecan analog 2 is a drug-linker conjugate composed of Camptothecin and a linker. Camptothecin (CPT) is a Topo I inhibitor with antineoplastic activity against colorectal, breast, lung and ovarian cancers. Deruxtecan analog 2 can be used for the preparation anti-FGFR2 ADC. |
|
| DC72257 | TAM558 | TAM558 is a payload molecule used for the synthesis of OMTX705. OMTX705 is a humanized anti-fibroblast-activating protein (FAP) antibody conjugated to the cytolysin TAM470, with antitumor activity. |
|
| DC72509 | Sulfo-SPP sodium | Sulfo-SPP sodium a heterobifunctional, thiol-cleavable and membrane impermeable crosslinker. |
|
| DC72510 | SC239 | SC239 is a cleavable 2-aminophenyl hemiasterlin drug-linker. SC239 can be as the drug-linker for ADC. |
|
| DC72511 | Mal-VC-PAB-PNP-CDN-A | Mal-VC-PAB-PNP-CDN-A is a drug-linker conjugate for ADC. |
|
| DC72512 | Mal-Val-Ala-PABA-cGAMP | Mal-Val-Ala-PABA-cGAMP is a ADC linker that can be connected to a STING agonist. Mal-Val-Ala-PABA-cGAMP can be used for the synthesis of antibody-drug conjugates (ADCs). |
|
| DC72513 | Fmoc-Ala-Ala-PAB | Fmoc-Ala-Ala-PAB is a cleavable ADC Linker (ADC Linker). Fmoc-Ala-Ala-PAB can be used in the synthesis of antibody-drug conjugates (ADCs). |
|
| DC72514 | Mal-VC-PAB-PNP | Mal-VC-PAB-PNP is a cleavable ADC Linker (ADC Linker). Mal-VC-PAB-PNP can be used in the synthesis of antibody-drug conjugates (ADCs). |
|
| DC72515 | MC-Ala-Ala-PAB | MC-Ala-Ala-PAB is a cleavable ADC Linker (ADC Linker). Fmoc-Ala-Ala-PAB can be used in the synthesis of antibody-drug conjugates (ADCs). |
|
| DC72516 | MP-Ala-Ala-PAB | MP-Ala-Ala-PAB is a cleavable ADC Linker (ADC Linker). Fmoc-Ala-Ala-PAB can be used in the synthesis of antibody-drug conjugates (ADCs). |
|
| DC72532 | Fmoc-VAP-MMAE | Fmoc-VAP-MMAE is a drug-linker conjugates for ADC. Fmoc-VAP-MMAE consists of an ADC linker and a tubulin inhibitor MMAE, with a protective Fmoc group. |
|
| DC72533 | ATAC21 | ATAC21, a linker-immune-stimulatory compound that can be formed by conjugating a noncleavable maleimide-PEG4 linker containing a succinimide group with an immune- stimulatory compound. ATAC21 can be combined with SBT-040 (anti-CD40 antibody) to form a conjugate. |
|
| DC72753 | Gly-Cyclopropane-Exatecan | Gly-Cyclopropane-Exatecan involves in the synthesis of anti-B7-H4 ADC, containing Exatecan, a DNA Topoisomerase I inhibitor. Gly-Cyclopropane-Exatecan participated in the formation of the ADC hu2F7-Exatecan (compound 34), which showed antitumor activity in vivo and in vitro. |
|
| DC72757 | MC-Gly-Gly-Phe-Boc | MC-Gly-Gly-Phe-Boc is involved in the synthesis of Antibody-Drug Conjugates (ADCs) to Trastuzumab. MC-Gly-Gly-Phe-Boc can participate in cancer research. |
|
| DC72886 | Dox-btn2 | Dox-btn2 is a biotinylated derivative of Doxorubicin, with a biotin label at the point of conjugation to doxorubicin at 3'-NH2. Dox-btn2 can be used for cell imaging. While Doxorubicin is mainly accumulated in the nucleus, while Dox-btn2 is mainly located in the cytoplasm. |
|
| DC65699 | Mal-propyl-Ala-Ala-Asn-PAB Featured | Mal-propyl-Ala-Ala-Asn(Trt)-PAB is a hetero bifunctional cross-linker, useful in antibody drug conjugation (ADC). |
|
| DC74469 | ZD06519 | ZD06519 is a novel camptothecin payload for antibody drug conjugates (ADCs) with highp ayload potency (~1 nM). |
|
| DC74470 | SuO-Val-Cit-PAB-MMAE Featured | A drug-linker conjugate for antibody-drug conjugate by using the anti-mitotic agent, monomethyl auristatin E (MMAE), linked via the cleavable peptide SuO-Val-Cit-PAB.. |
|
| DC74471 | EN106 derivative 1 | EN106 derivative 1 is a EN106 derivative used for PROTAC design, EN106 is a covalent ligand and recruiter for FEM1B E3 ligase for targeted protein degradation. |
|
